retatrutide ly3437943 glp-1 gip glucagon receptor agonist just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Retatrutide vs Tirzepatide & Semaglutide

And the demand for sophisticated ingredients like this is exploding

The two came together in a separate capsule

Foundayo offers a simple dosing schedule while delivering meaningful weight loss results backed by clinical trials

For people living with overweight or obesity, the experience tends to be even stronger many people said their relationship with food feels uncontrollable, and nearly 70% said it directly harms their mental health

Some other factors to consider regarding any surgery are: Age The older you are, the more risks there are with surgery

Article outro Author Tags Internal Medicine Diabetes Obesity General Internal Medicine Explore More Featured in this article